Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Molebogeng X Rangaka

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 9, 2013
Improving the predictive value of interferon-gamma release assays: do our methods go far enough?Sandra V Kik, Molebogeng X Rangaka
The Lancet. Respiratory Medicine|March 26, 2022
Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?Molebogeng X Rangaka, Yohhei Hamada, Ibrahim Abubakar
The Lancet. Respiratory Medicine|February 5, 2017
C-Tb: a latent tuberculosis skin test for the 21st century?Ibrahim Abubakar, Charlotte Jackson, Molebogeng X Rangaka
American Journal of Respiratory and Critical Care Medicine|December 10, 2019
The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large TrialsIbrahim Abubakar, Frank G J Cobelens, Molebogeng X Rangaka
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 4, 2018
Eliminating tuberculosis in low-burden countriesCharlotte Jackson, Ted Cohen, Molebogeng X Rangaka, et al.
American Journal of Respiratory and Critical Care Medicine|March 15, 2018
Update in Tuberculosis and Nontuberculous Mycobacteria 2017Ibrahim Abubakar, Rishi K Gupta, Molebogeng X Rangaka, et al.
BMC Public Health|June 29, 2026
A systematic review of the determinants of vaccine hesitancy in the UK: Implications for future TB vaccine adoptionAnnabel Kennard, Aysenur Kılıç, Dana Alsugeir, et al.
Expert Review of Molecular Diagnostics|October 3, 2006
QuantiFERON-TB Gold: state of the art for the diagnosis of tuberculosis infection?Tom G Connell, Molebogeng X Rangaka, Nigel Curtis, et al.
Computers in Biology and Medicine|May 19, 2018
Mobile phone-based evaluation of latent tuberculosis infection: Proof of concept for an integrated image capture and analysis systemSafa Naraghi, Tinashe Mutsvangwa, René Goliath, et al.
The Lancet. Infectious Diseases|November 28, 2020
Predictive performance of interferon-γ release assays and tuberculin skin testsYohhei Hamada, Rishi K Gupta, Alberto Matteelli, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 9, 2013
Improving the predictive value of interferon-gamma release assays: do our methods go far enough?Sandra V Kik, Molebogeng X Rangaka
The Lancet. Respiratory Medicine|March 26, 2022
Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?Molebogeng X Rangaka, Yohhei Hamada, Ibrahim Abubakar
The Lancet. Respiratory Medicine|February 5, 2017
C-Tb: a latent tuberculosis skin test for the 21st century?Ibrahim Abubakar, Charlotte Jackson, Molebogeng X Rangaka
American Journal of Respiratory and Critical Care Medicine|December 10, 2019
The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large TrialsIbrahim Abubakar, Frank G J Cobelens, Molebogeng X Rangaka
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 4, 2018
Eliminating tuberculosis in low-burden countriesCharlotte Jackson, Ted Cohen, Molebogeng X Rangaka, et al.
American Journal of Respiratory and Critical Care Medicine|March 15, 2018
Update in Tuberculosis and Nontuberculous Mycobacteria 2017Ibrahim Abubakar, Rishi K Gupta, Molebogeng X Rangaka, et al.
BMC Public Health|June 29, 2026
A systematic review of the determinants of vaccine hesitancy in the UK: Implications for future TB vaccine adoptionAnnabel Kennard, Aysenur Kılıç, Dana Alsugeir, et al.
Expert Review of Molecular Diagnostics|October 3, 2006
QuantiFERON-TB Gold: state of the art for the diagnosis of tuberculosis infection?Tom G Connell, Molebogeng X Rangaka, Nigel Curtis, et al.
Computers in Biology and Medicine|May 19, 2018
Mobile phone-based evaluation of latent tuberculosis infection: Proof of concept for an integrated image capture and analysis systemSafa Naraghi, Tinashe Mutsvangwa, René Goliath, et al.
The Lancet. Infectious Diseases|November 28, 2020
Predictive performance of interferon-γ release assays and tuberculin skin testsYohhei Hamada, Rishi K Gupta, Alberto Matteelli, et al.
Pageof 9